Delivery of pDNA to lung epithelial cells using PLGA nanoparticles formulated with a cell-penetrating peptide: understanding the intracellular fate. (3rd March 2020)
- Record Type:
- Journal Article
- Title:
- Delivery of pDNA to lung epithelial cells using PLGA nanoparticles formulated with a cell-penetrating peptide: understanding the intracellular fate. (3rd March 2020)
- Main Title:
- Delivery of pDNA to lung epithelial cells using PLGA nanoparticles formulated with a cell-penetrating peptide: understanding the intracellular fate
- Authors:
- Gomes dos Reis, Larissa
Lee, Wing-Hin
Svolos, Maree
Moir, Lyn M.
Jaber, Rima
Engel, Andrea
Windhab, Norbert
Young, Paul M.
Traini, Daniela - Abstract:
- Abstract: The combination of nanoparticles (NPs) and cell-penetrating peptide (CPP) represents a new opportunity to develop plasmid DNA (pDNA) delivery systems with desirable properties for lung delivery. In this study, poly(lactide-co-glycolide) (PLGA) NPs containing pDNA were formulated with and without CPP using a double-emulsion technique. NPs were characterized in regards of size, surface charge, release profile, pDNA encapsulation efficiency and pDNA integrity. Cellular uptake, intracellular trafficking, uptake mechanism and pDNA expression were assessed in both A549 and Beas-2B cells. Manufactured PLGA-NPs efficiently encapsulated pDNA with approximately 50% released in the first 24 h of incubation. Addition of CPP was essential to promote NP internalization in both cell lines, with 83.85 ± 1.2% and 96.76 ± 1.7% of Beas-2B and A549 cells, respectively, with internalized NP–DNA–CPP after 3 h of incubation. Internalization appears to occur mainly via clathrin-mediated endocytosis, with other pathways also being used by the different cell lines. An endosomal-escape mechanism seems to happen in both cell lines, and eGFP expression was observed in Beas-2B after 96 h of incubation. In summary, the NP–DNA–CPP delivery system efficiently encapsulated and protected pDNA structure and is being investigated as a promising tool for gene delivery to the lungs.
- Is Part Of:
- Drug development and industrial pharmacy. Volume 46:Number 3(2020)
- Journal:
- Drug development and industrial pharmacy
- Issue:
- Volume 46:Number 3(2020)
- Issue Display:
- Volume 46, Issue 3 (2020)
- Year:
- 2020
- Volume:
- 46
- Issue:
- 3
- Issue Sort Value:
- 2020-0046-0003-0000
- Page Start:
- 427
- Page End:
- 442
- Publication Date:
- 2020-03-03
- Subjects:
- Alveolar -- bronchial -- double-emulsion technique -- endocytic -- pathway -- gene delivery -- intracellular trafficking -- release
Pharmaceutical chemistry -- Periodicals
Pharmaceutical industry -- Periodicals
Drug Industry -- Periodicals
Technology, Pharmaceutical -- Periodicals
615.05 - Journal URLs:
- http://informahealthcare.com/loi/ddi ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/03639045.2020.1724134 ↗
- Languages:
- English
- ISSNs:
- 0363-9045
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.116000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13653.xml